DEFA5 and inflammatory bowel disease: Among potential diagnostic biomarkers, human alpha defensin 5 (DEFA5 alias HD5) has emerged as a promising candidate due to its differential expression patterns in CC and UC, making it a valuable target for IBD-subtype diagnostic development [1,80].